ALS/MND Platform Trials Update

Platform trials are reshaping how new therapies are tested in ALS/MND. Join us for updates from leaders of EXPERTS-ALS, HEALEY,  and SMART, who will share the latest on trial design, recruitment progress, eligibility criteria, and emerging developments.

This session offers an opportunity to better understand how these innovative trial models are advancing research and what they mean for people living with ALS/MND. (Multilingual captions available.)